[SYRS] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
27-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -233.81%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 9,936 14,880 23,488 15,093 1,982 2,050 1,101 44.26%
PBT -164,574 -94,654 -86,558 -84,038 -75,438 -62,279 -54,010 20.39%
Tax 0 -45,353 3,907 1,792 2,550 2,017 -1,527 -
NP -164,574 -49,301 -90,465 -85,830 -75,438 -62,279 -54,010 20.39%
Tax Rate - - - - - - - -
Total Cost 174,510 64,181 113,953 100,923 77,420 64,329 55,111 21.16%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -1,656.34 -331.32 -385.15 -568.67 -3,806.16 -3,038.00 -4,905.54 -16.54%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -5.81 -3.90 -14.47 -18.64 -18.76 -19.07 -21.26 -19.43%
EPS Diluted -5.81 -3.90 -14.47 -18.64 -18.76 -19.07 -21.26 -19.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.